TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Name: TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.
License: Public Domain

Tibotec Pharmaceuticals, Ireland

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hiv-1 hiv-infections

hiv infections, hiv-1, tmc114, early access, highly antiretroviral treatment experienced patients, anti-retroviral agents, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 866508
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.